SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-248197
Filing Date
2012-05-25
Accepted
2012-05-25 09:19:19
Documents
3
Period of Report
2012-05-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d358927d8k.htm 8-K 44256
2 AMENDMENT NO.2 TO THE AMENDED AND RESTATED BY-LAWS d358927dex31.htm EX-3.1 1921
3 2012 STOCK OPTION AND INCENTIVE PLAN d358927dex101.htm EX-10.1 85687
  Complete submission text file 0001193125-12-248197.txt   133314
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 12869484
SIC: 2836 Biological Products, (No Diagnostic Substances)